Boundless Bio Announces Pricing of IPO at $16 per Share
Thursday, 28 March 2024, 06:33
Boundless Bio IPO Pricing
Boundless Bio has successfully priced its IPO at $16 per share, aiming to raise $100 million in gross proceeds. The company is anticipating strong investor interest in its offering.
Investor Appetite
Boundless Bio's decision to price its shares at $16 demonstrates the company's confidence in the market's appetite for its debut offering.
Market Entrance
With the IPO pricing finalized, Boundless Bio is poised to enter the public markets with substantial capital to support its growth and expansion strategies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.